| Literature DB >> 29466454 |
Beatriz Pérez-Pérez1, Paula Cristóbal-Narváez2,3, Tamara Sheinbaum1, Thomas R Kwapil4, Sergi Ballespí1, Elionora Peña5,6, Marta de Castro-Catala5,6, Maria Dolors Riba7, Araceli Rosa3,5,6, Neus Barrantes-Vidal1,3,8.
Abstract
BACKGROUND: Gene-environment interaction (GxE) research has highlighted the importance of investigating the FK506 binding protein 51 (FKBP5) gene as a sensitivity gene. However, previous GxE studies with FKBP5 have not measured the full environmental spectrum or applied statistical tests to discern whether the GxE interaction fits better with the differential-susceptibility or diathesis-stress hypotheses. This study examined whether single nucleotide polymorphisms (SNPs) on FKBP5 gene moderate the association of positive and negative recent life events (LEs) with depressive symptoms, state-anxiety, neuroticism, and social anxiety traits.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29466454 PMCID: PMC5821376 DOI: 10.1371/journal.pone.0193044
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Descriptive statistics of self-reported measures (n = 86).
| Measure | Mean | α | Observed range | Theoretical range | |||
|---|---|---|---|---|---|---|---|
| Min. | Max. | Min. | Max. | ||||
| Depressive symptoms (BDI-II) | 5.58 | 6.41 | 0.89 | 0 | 33 | 0 | 63 |
| State-anxiety (BAI) | 5.51 | 5.81 | 0.89 | 0 | 39 | 0 | 63 |
| Neuroticism (NEO-PI-R) | 74.14 | 25.28 | 0.94 | 29 | 127 | 0 | 192 |
| Social anxiety & phobia (SPAI-B) | 21.07 | 11.97 | 0.95 | 0.36 | 50.17 | 0 | 64 |
| Live events impact (LESms) | 0.57 | 0.98 | - | -1.50 | 2.78 | -3 | 3 |
Note. BDI = Beck Depression Inventory-Second Edition; BAI = Beck Anxiety Inventory; Neuroticism = Neuroticism Subscale from NEO Personality Inventory–Revised; SPAI-B = Social Phobia and Anxiety Inventory-Brief form; LESms = Mean Score of the Life Experiences Survey.
Description of FKBP5 studied variants and comparison groups employed in multivariate regression analysis.
| FKBP5 variants description | Empirical background | Comparison groups | |||||
|---|---|---|---|---|---|---|---|
| SNP | Reference Sequence (rs) | Genotypic or Haplotypic combinations (n) | Non-risk allele | Risk allele | Genotype groups considered ( | Theoretical approach | |
| SNP1 | rs3800373 | A | 86 | N/N vs. Rc | |||
| SNP2 | rs9296158 | 86 | |||||
| SNP3 | rs1360780 | 86 | |||||
| SNP4 | rs9470080 | 86 | |||||
| SNP5 | rs4713916 | 86 | |||||
| HAPL | rs3800373 rs9296158 rs1360780 | 83 | N/N or N/X vs. Rc | ||||
Note. N = Non-risk; Rc = Risk carriers; HAPL = Haplotype; XXX & X = Other haplotype combinations (AAC, AAT, CGC, CGT, CAC or AGT).
a Risk and non-risk alleles according to Zannas and Binder (2014).
b Corresponds to the observations accounted in multivariate regression models for the different FKBP5 moderators.
Regression estimates, significant simple slopes, and differential susceptibility/diathesis–stress indices by criterion domain.
| Regression estimates | Significant simple slopes | Differential-susceptibility/diathesis-stress indices | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | 95% CI | RoS X | PoI | PA | Cross | |||||||||
| Lower bound | Upper bound | |||||||||||||
| SNP1 | 7.455 | -2.019 | -0.795 | -0.730 | 0.132 | 0.590 | _ | _ | _ | _ | _ | _ | _ | _ |
| SNP2 | 7.489 | -1.980 | -0.739 | -1.035 | 0.138 | 0.438 | _ | _ | _ | _ | _ | _ | _ | _ |
| SNP3 | 6.541 | -1.689 | 1.098 | -1.791 | 0.140 | 0.177 | _ | _ | _ | _ | _ | _ | _ | _ |
| SNP4 | 8.088 | -2.792 | -1.898 | 0.571 | 0.138 | 0.670 | _ | _ | _ | _ | _ | _ | _ | _ |
| SNP5 | 7.583 | -2.595 | -1.124 | 0.599 | 0.128 | 0.964 | _ | _ | _ | _ | _ | _ | _ | _ |
| HAPL | 7.436 | -2.046 | -0.366 | -1.212 | 0.139 | 0.387 | _ | _ | _ | _ | _ | _ | _ | _ |
| SNP1 | 5.857 | -0.394 | 1.186 | -1.898 | 0.048 | 0.142 | _ | _ | _ | _ | _ | _ | _ | _ |
| SNP2 | 5.756 | -0.449 | 1.476 | -2.148 | 0.057 | 0.092 | _ | _ | _ | _ | _ | _ | _ | _ |
| SNP3 | 5.298 | -0.383 | 2.126 | -2.221 | 0.065 | 0.078 | _ | _ | _ | _ | _ | _ | _ | _ |
| SNP4 | 5.663 | -0.944 | 1.189 | -0.869 | 0.032 | 0.500 | _ | _ | _ | _ | _ | _ | _ | _ |
| SNP5 | 5.482 | -0.815 | 1.671 | -1.306 | 0.042 | 0.305 | _ | _ | _ | _ | _ | _ | _ | _ |
| HAPL | 5.825 | -0.656 | 1.603 | -2.215 | 0.069 | 0.096 | _ | _ | _ | _ | _ | _ | _ | _ |
| SNP1 | 76.944 | 0.013 | 4.113 | -12.464 | 0.102 | 0.024 | -12.45 | [-19.72, -5.19] | 0.001 | -2.076 | 1.555 | 0.62 | 0.37 | 0.330 |
| SNP2 | 75.930 | -1.153 | 6.626 | -12.819 | 0.104 | 0.019 | -13.97 | [-21.81, -6.13] | 0.001 | -1.045 | 1.867 | 0.52 | 0.30 | 0.517 |
| SNP3 | 73.990 | -1.939 | 8.926 | -10.909 | 0.091 | 0.044 | -12.85 | [-20.53, -5.17] | 0.001 | -0.878 | 11.613 | 0.37 | 0.21 | 0.818 |
| SNP4 | 77.990 | -5.759 | 0.402 | -2.163 | 0.043 | 0.697 | _ | _ | _ | _ | _ | _ | _ | _ |
| SNP5 | 77.971 | -5.463 | 0.383 | -3.729 | 0.048 | 0.499 | _ | _ | _ | _ | _ | _ | _ | _ |
| HAPL | 76.514 | -2.724 | 7.405 | -12.651 | 0.123 | 0.024 | -15.38 | [-23.60, -7.15] | <0.001 | -1.025 | 2.287 | 0.49 | 0.28 | 0.585 |
| SNP1 | 20.849 | -0.204 | 5.106 | -6.037 | 0.107 | 0.021 | -6.24 | [-9.67, -2.81] | 0.001 | 0.358 | 9.59 | 0.18 | 0.10 | 1.278 |
| SNP2 | 20.243 | -0.951 | 6.315 | -5.610 | 0.111 | 0.029 | -6.56 | [-10.26, -2.87] | 0.001 | 0.190 | 6.505 | 0.24 | 0.13 | 1.126 |
| SNP3 | 19.428 | -1.459 | 6.918 | -4.179 | 0.108 | 0.099 | _ | _ | _ | _ | _ | _ | _ | _ |
| SNP4 | 20.197 | -0.961 | 5.092 | -4.293 | 0.085 | 0.098 | _ | _ | _ | _ | _ | _ | _ | _ |
| SNP5 | 20.843 | -2.171 | 4.216 | -2.415 | 0.065 | 0.352 | _ | _ | _ | _ | _ | _ | _ | _ |
| HAPL | 20.689 | -0.630 | 6.213 | -5.896 | 0.098 | 0.027 | -6.53 | [-10.43, -2.62] | 0.001 | 0.124 | 5.365 | 0.27 | 0.15 | 1.054 |
Note. SNP1 = rs3800373; SNP2 = rs9296158; SNP3 = rs1360780; SNP4 = rs9470080; SNP5 = rs4713916; HAPL = Haplotype
R = adjusted R-squared; RoS X = Regions of Significance with respect to X; PoI = Proportion of Interaction index; PA = Proportion Affected index; Cross = Crossover point at which the regression lines intersect.
a The regression equation Y = b0 + b1X + b2Z + b3XZ, where X is life events (LESms) and Z is FKBP5 variant.
b In all cases significant simple slopes were only found in the groups of risk-carriers (Z = 1).
c p value of the interaction term.
d RoS on X indices falling within 2 SD from the mean of the predictor (LESms).
* p < 0.05.
** p < 0.001.
Fig 1The four significant interactions of FKBP5 variants with recent live events (LESms) for neuroticism, with Regions of significance on X (shaded areas).
Description: Blue lines represent nonrisk-groups and black lines risk-groups. Graph (a) shows a vantage sensitivity effect: the group of individuals carrying the risk-allele (C) only differ from the nonrisk-group (A/A), showing significantly lower neuroticism when they experienced more positive LEs. Graphs (b) and (d) demonstrate a differential-susceptibility effect: risk-groups, with respect to nonrisk-groups, have significantly higher neuroticism if they experienced more negative LEs, as well as significantly lower neuroticism if they experienced more positive LEs. Graph (c) shows a diathesis-stress effect: the risk-group differed from the nonrisk-group, showing significantly higher neuroticism when they experienced more negative LEs. All graphs were plotted at 2 SD from LESms (range; -1.401, 2.532).
Fig 2The three significant interactions of FKBP5 variants with recent live events (LESms) for social anxiety, with Regions of significance on X (shaded areas).
Description: Blue lines represent nonrisk-groups and black lines risk-groups. All 3 graphs demonstrate a diathesis-stress effect: the risk-groups only differed from the nonrisk-groups by showing significantly higher social anxiety if they experienced more negative life events. All graphs were plotted at 2 SD from the mean of LESms (range; -1.401, 2.532).